Biotechnology Daily
more-
How roundworms could inspire new treatments for obesity and other food-related diseases
By studying the simple nematode worm Caenorhabditis elegans, a team led by scientists at the…
Agilent to pick up cancer blood tester Resolution Bio in $695M deal
From the big screen, to the small screen, to the MRI—Disney teams with Philips to bring its characters to pediatric imaging
Harvard stem cell research lead Jonathan Hoggatt joins Moderna as director of hematology
Inhibiting pancreatic cancer by exploiting a protein loophole
Market Watch
more-
Weekly Market Review – March 6, 2021
Stock Markets Stocks pulled back as yields moved up, continuing the cycle of volatility of…
Bio Business News
more
Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset
After seeing the biotech’s shares soar 300% late last year…
Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture
Another phase 3 clinical trial of Eli Lilly’s tirzepatide in…
Biden still pushing for his cancer ‘breakthrough’ dream, but can it work?
Like so many in the world, President Joe Biden has…
World News
more
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
Weekly Market Review – March 6, 2021- The Small Biotech Company That All The Majors Aspire To Be
How roundworms could inspire new treatments for obesity and other food-related diseases
Agilent to pick up cancer blood tester Resolution Bio in $695M deal
From the big screen, to the small screen, to the MRI—Disney teams with Philips to bring its characters to pediatric imaging
Harvard stem cell research lead Jonathan Hoggatt joins Moderna as director of hematology
Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset
Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture
Biden still pushing for his cancer ‘breakthrough’ dream, but can it work?
BlackRock powers Exscientia to $100M series C round to fund autonomous drug design